4 weeks HC Wainwright Reiterates Buy Rating for NovoCure (NASDAQ:NVCR)MarketBeat
HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of NovoCure in a research report on Thursday.
XHC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of NovoCure in a research report on Thursday.
X